References

Cancer statistics, 2024

10.3322/caac.21820 · 2024 · External reference

Unresolved reference

External reference

Recent advances in the management of metastatic prostate cancer

10.1200/op.21.00206 · 2022 · External reference

Racial and ethnic composition of cancer clinical drug trials: How diverse are we

10.1634/theoncologist.2017-0237 · 2018 · External reference

Increasing racial and ethnic diversity in cancer clinical trials: An American Society of Clinical Oncology and Association of Community Cancer Centers joint research statement

10.1200/jco.22.00754 · 2022 · External reference

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

10.3322/caac.21638 · 2021 · External reference

Social determinants of health and the availability of cancer clinical trials in the United States

10.1001/jamanetworkopen.2024.10162 · 2024 · External reference

Participation of older patients with prostate cancer in Medicare eligible trials

10.1016/j.juro.2010.04.076 · 2010 · External reference

Disparities in the inclusion of racial and ethnic minority groups and older adults in prostate cancer clinical trials

10.1001/jamaoncol.2022.5511 · 2023 · External reference

A systematic review of patient race, ethnicity, socioeconomic status, and educational attainment in prostate cancer treatment randomised trials—is the evidence base applicable to the general patient population

10.1016/j.euros.2023.05.015 · 2023 · External reference

National estimates of the participation of patients with cancer in clinical research studies based on Commission on Cancer accreditation data

10.1200/jco.23.01030 · 2024 · External reference

Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer

10.1001/jamaoncol.2022.5020 · 2022 · External reference

Comparison of survival outcomes among cancer patients treated in and out of clinical trials

10.1093/jnci/dju002 · 2014 · External reference

Examining the racial disparities in prostate cancer

10.1016/j.urology.2021.08.004 · 2022 · External reference

Health disparities in prostate cancer and approaches to advance equitable care

10.1200/edbk_350751 · 2022 · External reference

Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action

10.1186/s13063-021-05849-7 · 2021 · External reference

Inclusion and diversity in clinical trials: Actionable steps to drive lasting change

10.1016/j.cct.2022.106740 · 2022 · External reference

Why diverse clinical trial participation matters

10.1056/nejmp2215609 · 2023 · External reference

Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: Enhancing minority participation in clinical trials (EMPaCT)

10.1002/cncr.28574 · 2014 · External reference

Barriers and strategies for recruitment of racial and ethnic minorities: Perspectives from neurological clinical research coordinators

10.1007/s40615-016-0332-y · 2017 · External reference

Enhancing the diversity of clinical trial populations - eligiblity criteria, enrollment practices, and trial designs guidance for industry

2020 · External reference

Assessing barriers to prostate cancer clinical trial participation among Black and African Americans: A multi-perspective qualitative study

10.1200/jco.2024.42.16_suppl.e13682 · 2024 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

10.1016/0021-9681(87)90171-8 · 1987 · External reference

Disparities in clinical trial participation beyond first-line treatment among patients with metastatic breast or colorectal cancer

10.1200/op.2023.19.11_suppl.97 · 2023 · External reference

Metastatic hormone-sensitive prostate cancer (mHSPC): Advances and treatment strategies in the first-line setting

10.1007/s40487-020-00119-z · 2020 · External reference

Metastatic castration-resistant prostate cancer: Insights on current therapy and promising experimental drugs

10.2147/rru.s385257 · 2023 · External reference

Updates to advanced prostate cancer: AUA/SUO guideline (2023)

10.1097/ju.0000000000003452 · 2023 · External reference

Physician visits prior to treatment for clinically localized prostate cancer

10.1001/archinternmed.2010.1 · 2010 · External reference

Examining exclusion criteria in advanced prostate cancer clinical trials: An assessment of recommendations from the American Society Of Clinical Oncology and Friends of Cancer Research

10.1016/j.clgc.2023.05.013 · 2023 · External reference

The effect of clinical trial participation versus non‐participation on overall survival in men receiving first‐line docetaxel‐containing chemotherapy for metastatic castration‐resistant prostate cancer

10.1111/j.1464-410x.2012.11286.x · 2012 · External reference

The effect of comorbidity on participation in early phase cancer trials

10.1200/jco.2016.34.15_suppl.2534 · 2016 · External reference

Association of patient comorbid conditions with cancer clinical trial participation

10.1001/jamaoncol.2018.5953 · 2019 · External reference

Motivation to clinical trial participation: Health information distrust and healthcare access as explanatory variables and gender as moderator

10.3390/jcm14020485 · 2025 · External reference

Unresolved reference

External reference

Racial disparities in access to prostate cancer clinical trials: A county-level analysis

10.1093/jncics/pkab093 · 2021 · External reference

Winning hearts & minds: Prostate cancer outreach and clinical trial enrollment in minority men

10.21037/tcr-24-868 · 2024 · External reference

Drivers of racial disparities in prostate cancer trial enrollment

10.1038/s41391-021-00427-z · 2021 · External reference

Racial disparities in clinical trial enrollment among patients diagnosed with prostate cancer: A population‐based cohort of oncology practices

10.1155/aiu/8871425 · 2024 · External reference

Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trials

2023 · External reference

Minority recruitment trends in phase III prostate cancer clinical trials (2003-2014): Progress and critical areas for improvement

10.1016/j.juro.2018.09.029 · 2018 · External reference

Diversity of enrollment in prostate cancer clinical trials: Current status and future directions

10.1158/1055-9965.epi-19-1616 · 2020 · External reference

Dedicated research navigators: A tool to decrease disparities in clinical trial enrollment

10.1016/j.ijgc.2024.100066 · 2025 · External reference

Selection and prejudice: Addressing clinical trial disparities with a review of current shortcomings and future directions

10.1016/j.semradonc.2023.06.002 · 2023 · External reference

Advancing inclusive research: Establishing collaborative strategies to improve diversity in clinical trials

10.18865/ed.32.1.61 · 2022 · External reference

Overcoming barriers: Evidence-based strategies to increase enrollment of underrepresented populations in cancer therapeutic clinical trials—a narrative review

10.1007/s13187-019-01650-y · 2020 · External reference